Saturday 17 October 2026
Export MMSI’s income statement to Excel — free account
Merit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 9.51%, EPS grew 18.2%, free cash flow fell 25.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
89.20
0.37
−0.41%
Follow MMSI
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
58.22 | 73.81 | 69.76 | 346.89 | 0.00 | 72.44 | 53.13 | 46.57 | 46.72 | 40.62 |
Piotroski F-Score |
5 | 7 | 4 | 5 | 3 | 7 | 7 | 6 | 6 | 7 |
P/S ratio |
1.93 | 2.92 | 3.30 | 1.73 | 3.19 | 3.25 | 3.44 | 3.50 | 4.15 | 3.44 |
Altman Z-Score |
2.98 | 4.28 | 3.71 | 2.35 | 3.67 | 4.75 | 6.13 | 3.87 | 4.78 | 4.42 |
P/FCF ratio |
62.67 | 98.64 | 144.04 | 0.00 | 26.52 | 29.77 | 59.77 | 40.56 | 30.81 | 24.53 |
Altman Z″-Score (non-manufacturers) |
3.52 | 3.96 | 3.43 | 3.00 | 3.09 | 3.82 | 4.82 | 4.84 | 4.68 | 4.93 |
Beneish M-Score |
(2.58) | (2.30) | (2.30) | (2.59) | (2.98) | (2.70) | (2.52) | (2.90) | (2.46) | (2.70) |
P/Operating CF |
67.41 | 109.93 | 123.21 | 63.90 | 83.36 | 76.35 | 141.16 | 70.66 | 81.91 | 52.93 |
P/B ratio |
2.34 | 3.14 | 3.13 | 1.81 | 3.21 | 3.36 | 3.45 | 3.66 | 4.08 | 3.29 |
Price to Tangible BV |
11.23 | 10.08 | 21.67 | 11.35 | 13.55 | 9.75 | 7.77 | 8.91 | 13.48 | 9.66 |
EV/Sales |
2.43 | 3.26 | 3.68 | 2.13 | 3.50 | 3.42 | 3.56 | 3.69 | 4.41 | 3.63 |
EV/EBITDA |
18.49 | 27.20 | 25.19 | 17.57 | 31.89 | 23.37 | 22.71 | 20.45 | 21.61 | 16.94 |
EV/Operating CF |
27.40 | 37.81 | 37.50 | 27.18 | 20.40 | 24.95 | 35.81 | 31.96 | 27.12 | 18.51 |
EV/FCF |
79.12 | 110.06 | 160.22 | (765.05) | 29.06 | 31.26 | 61.88 | 42.77 | 32.76 | 25.90 |
Quick Ratio |
1.23 | 1.31 | 1.26 | 1.19 | 1.18 | 1.03 | 1.09 | 3.83 | 2.72 | 2.82 |
Current Ratio |
2.76 | 2.73 | 2.45 | 2.50 | 2.32 | 2.04 | 2.40 | 5.45 | 4.27 | 4.34 |
Net Debt/EBITDA |
3.84 | 2.82 | 2.54 | 3.28 | 2.78 | 1.11 | 0.77 | 1.04 | 1.27 | 0.89 |
Debt/Assets |
34.41% | 25.05% | 24.39% | 25.01% | 21.10% | 14.73% | 11.90% | 35.39% | 30.16% | 27.33% |
Debt/Equity |
0.65 | 0.41 | 0.42 | 0.46 | 0.37 | 0.23 | 0.17 | 0.68 | 0.53 | 0.46 |
Asset Turnover |
0.70 | 0.71 | 0.65 | 0.59 | 0.56 | 0.65 | 0.70 | 0.63 | 0.57 | 0.59 |
Operating CF/Net income |
2.66 | 2.28 | 2.06 | 14.28 | (16.79) | 3.04 | 1.53 | 1.54 | 1.83 | 2.31 |
Capex/Depreciation |
(0.79) | (0.76) | (0.94) | (0.77) | (0.46) | (0.31) | (0.52) | (0.36) | (0.31) | (0.61) |
Interest Coverage |
3.96 | 4.27 | 5.66 | 1.24 | (0.16) | 11.58 | 13.81 | 7.99 | 4.99 | 6.98 |
| 4.17% | 4.69% | 5.22% | 0.58% | (1.03%) | 4.85% | 6.82% | 8.05% | 9.33% | 8.67% | |
| 2.34% | 2.68% | 3.08% | 0.32% | (0.58%) | 2.93% | 4.50% | 4.73% | 5.07% | 5.03% | |
ROIC |
2.71% | 2.24% | 2.91% | 0.72% | (0.08%) | 3.13% | 4.26% | 5.39% | 5.62% | 6.17% |
Return on Tangible Assets |
4.66% | 5.58% | 7.17% | 0.84% | (1.57%) | 7.85% | 10.78% | 7.33% | 11.01% | 10.46% |
Average Days of Receivables |
53.87 | 59.88 | 63.52 | 63.11 | 61.21 | 59.90 | 57.83 | 56.11 | 57.16 | 55.03 |
Research and Development Expense of Revenue |
7.49% | 7.06% | 6.74% | 6.60% | 5.97% | 6.63% | 6.56% | 6.58% | 6.45% | 6.42% |
Selling, General and Administrative Expense of Revenue |
30.54% | 31.48% | 31.27% | 32.90% | 30.89% | 31.23% | 29.76% | 29.72% | 29.47% | 30.03% |
Intangible Assets out of Total Assets |
0.42 | 0.42 | 0.49 | 0.45 | 0.44 | 0.41 | 0.38 | 0.30 | 0.40 | 0.39 |
Share Based Compensation of Revenue |
0.42% | 0.56% | 0.69% | 0.94% | 1.49% | 1.50% | 1.57% | 1.70% | 2.10% | 2.87% |
Graham Net Nets |
(0.17) | (0.06) | (0.09) | (0.21) | (0.09) | (0.04) | 0.00 | 0.00 | (0.02) | (0.01) |
Graham Number |
10.66 | 13.56 | 17.92 | 5.91 | 0.00 | 18.93 | 24.37 | 27.75 | 33.22 | 36.16 |
Earnings Yield |
1.72% | 1.35% | 1.43% | 0.29% | (0.31%) | 1.38% | 1.88% | 2.15% | 2.14% | 2.46% |
Free Cash Flow Yield |
1.60% | 1.01% | 0.69% | (0.16%) | 3.77% | 3.36% | 1.67% | 2.47% | 3.25% | 4.08% |
Revenue per Share |
13.60 | 14.91 | 16.89 | 18.06 | 17.39 | 19.14 | 20.26 | 21.83 | 23.30 | 25.62 |
Operating CF per Share |
1.21 | 1.29 | 1.66 | 1.41 | 2.98 | 2.62 | 2.01 | 2.52 | 3.79 | 5.03 |
Capex per Share |
(0.79) | (0.84) | (1.27) | (1.46) | (0.89) | (0.53) | (0.85) | (0.64) | (0.65) | (1.43) |
Free Cash Flow per Share |
0.42 | 0.44 | 0.39 | (0.05) | 2.09 | 2.09 | 1.16 | 1.88 | 3.14 | 3.59 |
Cash per Share |
0.43 | 0.66 | 1.29 | 0.80 | 1.03 | 1.21 | 1.03 | 10.19 | 6.47 | 7.55 |
Shareholders Equity per Share |
11.22 | 13.86 | 17.85 | 17.25 | 17.29 | 18.52 | 20.15 | 20.87 | 23.69 | 26.78 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.22 | 13.86 | 17.85 | 17.25 | 17.29 | 18.52 | 20.15 | 20.87 | 23.69 | 26.78 |
Free Cash Flow |
18.56 | 21.55 | 20.25 | (2.76) | 116.04 | 117.50 | 66.15 | 108.45 | 182.76 | 212.54 |
Working Capital |
155.09 | 200.50 | 254.49 | 272.88 | 244.70 | 245.93 | 308.44 | 904.91 | 707.37 | 800.39 |
Capital Expenditures |
(35.03) | (41.18) | (66.28) | (80.58) | (49.23) | (29.74) | (48.14) | (36.70) | (38.04) | (84.84) |
Net Current Asset Value |
(201.19) | (119.36) | (257.40) | (352.84) | (276.11) | (126.28) | 9.52 | (14.77) | (115.47) | (61.46) |
EV/EBIT |
42.11 | 71.72 | 55.36 | 137.01 | 0.00 | 60.29 | 46.75 | 37.43 | 38.46 | 29.80 |
Capex to Sales |
0.06 | 0.06 | 0.08 | 0.08 | 0.05 | 0.03 | 0.04 | 0.03 | 0.03 | 0.06 |
Price to Operating Income |
33.36 | 64.27 | 49.77 | 111.41 | 0.00 | 57.42 | 45.15 | 35.49 | 36.17 | 28.23 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.16 | 0.18 | 0.21 | 0.28 | 0.28 | 0.26 | 0.24 | 0.27 | 0.31 | 0.33 |
Cash ROIC |
2.21% | 2.18% | 1.45% | (0.19%) | 8.49% | 8.70% | 4.72% | 4.15% | 7.35% | 7.69% |
Accounts Receivable Turnover |
7.09 | 6.98 | 6.47 | 6.11 | 5.78 | 6.36 | 6.42 | 6.69 | 6.69 | 6.87 |
Accounts Payable Turnover |
9.88 | 12.25 | 10.97 | 10.35 | 10.77 | 11.18 | 10.18 | 10.02 | 10.61 | 12.05 |
Inventory Turnover |
2.99 | 2.91 | 2.77 | 2.66 | 2.66 | 2.81 | 2.59 | 2.36 | 2.34 | 2.43 |
Average Days of Payables |
32.99 | 31.75 | 40.41 | 35.45 | 32.33 | 34.45 | 39.57 | 35.74 | 35.06 | 28.42 |
Days of Inventory on Hand |
130.02 | 141.14 | 147.75 | 146.46 | 128.45 | 137.43 | 153.65 | 164.68 | 156.64 | 156.63 |
Average Receivables |
85.14 | 104.26 | 136.51 | 162.82 | 166.84 | 169.02 | 179.38 | 187.82 | 202.86 | 220.50 |
Average Payables |
34.30 | 32.78 | 44.48 | 54.32 | 52.23 | 52.73 | 62.06 | 67.22 | 67.22 | 64.53 |
Average Inventory |
113.35 | 137.99 | 176.41 | 211.62 | 211.86 | 209.97 | 243.96 | 284.93 | 304.97 | 319.88 |
Average Assets |
860.77 | 1,027.31 | 1,365.91 | 1,688.67 | 1,710.86 | 1,656.35 | 1,656.13 | 1,994.61 | 2,371.92 | 2,552.26 |
Average Common Equity |
482.15 | 587.26 | 804.55 | 941.36 | 954.26 | 999.19 | 1,092.10 | 1,173.20 | 1,290.68 | 1,481.83 |
Columns are period end dates